FundedIQ
Biotechnology

Stablepharma Ltd: Funding, Investors & Team (Sep 2026)

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology. The company actively collaborates with global vaccine manufacturers, academic institutions and NGOs, to advance their pipeline of thermostable products.

stablepharma.com LinkedIn Bath, United Kingdom 11-50 employees
Biotechnology Commercial Health Care Impact Investing Medical Device Pharmaceutical Product Research Wellness
Total raised
$2.6M
Rounds
1
Latest
Undisclosed round
Feb 2025

Stablepharma Ltd has raised $2.6M across 1 funding round on record, the most recent an undisclosed round of $2.6M announced in Feb 2025.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Stablepharma Ltd Company Profile and Key Stats

Total funding raised
$2.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.6M in Feb 2025
Employees
11-50
reported band
Headquarters
Bath, United Kingdom

Latest funding round on record: Feb 2025.

Stablepharma Ltd Funding Rounds

Date
Round
Amount
Undisclosed round
$2.6M

Stablepharma Ltd Founders and Leadership Team

Name
Role
Contact
Dr Bruce Roser
Founder

No contact details are on record for this team yet.

Stablepharma Ltd Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
5,273
$4.0M

Stablepharma Ltd's latest round of $2.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Stablepharma Ltd in Biotechnology and Bath

Companies Similar to Stablepharma Ltd

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Five is a biometric payment services company that offers thumb recognition technology for safe transactions.

Seed $6.0M

Stablepharma Ltd Funding FAQs

What does Stablepharma Ltd do?

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology. The company actively collaborates with global vaccine manufacturers, academic institutions and NGOs, to advance their pipeline of thermostable products.

How much funding has Stablepharma Ltd raised?

Stablepharma Ltd has raised $2.6M across 1 round on record. The most recent is an undisclosed round of $2.6M announced in Feb 2025.

When did Stablepharma Ltd last raise funding?

Stablepharma Ltd's most recent funding round on record is an undisclosed round of $2.6M, announced in Feb 2025.

Who founded Stablepharma Ltd?

FundedIQ lists Dr Bruce Roser (Founder) at Stablepharma Ltd.

Where is Stablepharma Ltd headquartered?

Stablepharma Ltd is based in Bath, Bath And North East Somerset, United Kingdom.

How many employees does Stablepharma Ltd have?

Stablepharma Ltd is in the 11-50 employee band.

How does Stablepharma Ltd's funding compare to other Biotechnology startups?

Stablepharma Ltd's latest round of $2.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Stablepharma Ltd Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stablepharma Ltd is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.